Provenance du réseau au premier degré de Tony Chase
Entité | Type d'entité | Industrie | |
---|---|---|---|
Public Company | Biotechnology | 14 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Tony Chase via son réseau personnel
Société | Secteur | Personnes liées | Poste principal |
---|---|---|---|
BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal | |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Corporate Officer/Principal Sales & Marketing Director/Board Member | |
PONIARD PHARMACEUTICALS, INC. | Biotechnology | Chief Executive Officer Director/Board Member | |
Soros Fund Management LLC
Soros Fund Management LLC Investment ManagersFinance Soros Fund Management LLC (SFM) is a privately-held investment management firm now structured as a family office, but which was once a hedge fund manager. The firm was founded in 1969 and is headquartered in New York City. SFM serves as the principal asset manager for the Open Society Foundations (Open Society) – a private funder of independent groups that works for justice, democratic governance, and human rights. | Investment Managers | Analyst-Equity | |
BIOMARIN PHARMACEUTICAL INC. | Biotechnology | Corporate Officer/Principal | |
BLACKBERRY LIMITED | Packaged Software | Director/Board Member | |
AUDIOEYE, INC. | Internet Software/Services | Chief Executive Officer | |
Arvinas Operations, Inc.
Arvinas Operations, Inc. BiotechnologyHealth Technology Arvinas Operations, Inc. develops novel therapeutics for the treatment of cancer, pro-inflammatory, autoimmune and rare diseases. It offers proteolysis-targeting chimera PROTAC-based drugs that induce protein degradation to target and eliminate disease-causing proteins from the body. The company was founded by Craig M. Crews in July 2013 and is headquartered in New Haven, CT. | Biotechnology | Director/Board Member | |
City University of New York | College/University | Doctorate Degree | |
Fordham University
Fordham University Other Consumer ServicesConsumer Services Fordham University provides college and university. It offers undergraduate colleges and graduate & professional schools. The company was founded in 1841 and is headquartered in Bronx, NY. | College/University | Undergraduate Degree | |
Regis University | College/University | Masters Business Admin | |
RBC Capital Markets LLC
RBC Capital Markets LLC Investment Banks/BrokersFinance RBC Capital Markets LLC is a full-service brokerage and financial services firm headquartered in New York City. They are a direct subsidiary of RBC USA Holdco Corp. and a wholly-owned indirect subsidiary of Royal Bank of Canada (TSE, NYSE: RY). Founded in 2010, the firm is comprised of 3 major business lines: the Private Client Group, the Fixed-Income Group and the Clearing and Execution Services Group. The Private Client Group serves individual investors, while the Fixed-Income Group provides services to institutions, municipalities and non-profit organizations. The Clearing and Execution Services Group is a provider of clearing and execution services to independent brokers/dealers throughout the US. RBC Capital Markets focuses on the following sectors: communications, media, consumer/retail, diversified industries, energy, financial institutions, forest products, healthcare, infrastructure finance, mining & metals, real estate, social infrastructure, technology and the US municipal markets. | Investment Banks/Brokers | Corporate Officer/Principal | |
Baruch College | College/University | Undergraduate Degree Undergraduate Degree | |
PLUS THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
PDL BIOPHARMA, INC. | Biotechnology | Comptroller/Controller/Auditor Director/Board Member | |
Healthcare Royalty Management LLC
Healthcare Royalty Management LLC Investment ManagersFinance Healthcare Royalty Management LLC (Healthcare Royalty) is a private equity subsidiary of Cowen, Inc. founded in 2007 by Gregory Brown. The firm is headquartered in Stamford, Connecticut. | Investment Managers | Director/Board Member | |
Estabrook Capital Management LLC
Estabrook Capital Management LLC Investment ManagersFinance Estabrook Capital Management LLC (Estabrook) is an independent registered investment advisor headquartered in New York City. Founded in 2008, Estabrook advises individually managed accounts for individuals, trusts, corporations, charitable organizations, and pension plans. The firm is also a portfolio manager in various wrap programs sponsored by non-affiliated organizations. | Investment Managers | Corporate Officer/Principal | |
Yorkville Capital Management LLC
Yorkville Capital Management LLC Investment ManagersFinance Yorkville Capital Management LLC (YCM) is an independent SEC-registered wealth management firm headquartered in New York City. The firm was founded in 2006 by Darren Schuringa. YCM provides investment advice and investment supervisory services to institutional clients, high-net worth individuals, separately managed vehicles (wrap fee programs), trusts, estates, and/or charitable organizations (such as foundations), ERISA plans, pension plans, profit-sharing plans, insurance companies, and corporations. | Investment Managers | Corporate Officer/Principal | |
NDA Group AB
NDA Group AB Miscellaneous Commercial ServicesCommercial Services NDA Group AB provides drug developmental consultancy services to the pharmaceutical industry. It focuses on all phases of development and therapeutic areas such as pre-submission, submission, assessment, post authorization, regulatory, pharmacovigilance, and health technology assessment. The company was founded in 1997 and is headquartered in Upplands Väsby, Sweden. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
National Institute for Bioprocessing Research & Training
National Institute for Bioprocessing Research & Training BiotechnologyHealth Technology The National Institute for Bioprocessing Research & Training (NIBRT) is a center of excellence for training and research in biopharmaceutical manufacturing. NIBRT operates in a world-class facility in Ireland, purpose-built to closely replicate a modern bioprocessing plant with state-of-the-art equipment. NIBRT offers the highest quality training and research solutions to support the growth and development of the biopharma manufacturing industry. | Biotechnology | Director/Board Member | |
University of California | College/University | Undergraduate Degree | |
Cooper Biomedical, Inc.
Cooper Biomedical, Inc. Medical SpecialtiesHealth Technology Cooper Biomedical, Inc. manufactures and sells medical devices. The private company is based in Malvern, PA. | Medical Specialties | Corporate Officer/Principal | |
TRAVERE THERAPEUTICS, INC. | Pharmaceuticals: Major | Chairman Founder | |
THERAVANCE BIOPHARMA, INC. | Pharmaceuticals: Major | Director/Board Member | |
Yale School of Medicine | College/University | Doctorate Degree | |
PharmApprove LLC
PharmApprove LLC Miscellaneous Commercial ServicesCommercial Services PharmApprove LLC provides strategic regulatory and scientific communications consultancy services to the pharmaceutical and biotech industries. The firm offers both strategic and tactical support to companies facing high-profile, high stakes events and engagements anywhere along the road to approval and commercialization -including FDA Advisory Committee meetings. The company was founded by Pete Taft in 1999 and is headquartered in Lawrenceville, NJ. | Miscellaneous Commercial Services | President | |
Phoenixus AG
Phoenixus AG Pharmaceuticals: MajorHealth Technology Phoenixus AG operates as a research-based pharmaceutical company. It develops and commercializes treatments for diseases and conditions with limited or no treatment options. The firm's products include Daraprim and Vecamyl. The company was founded by Martin Shkreli on February 24, 2015 and is headquartered in Baar, Switzerland. | Pharmaceuticals: Major | Founder Investor Relations Contact | |
ARVINAS, INC. | Biotechnology | Director/Board Member | |
Vyera Pharmaceuticals LLC
Vyera Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Vyera Pharmaceuticals LLC operates as a biopharmaceutical company that focuses on patients with unmet medical needs. Its products include Vecamyl and Daraprim. The firm engages in developing and commercializing treatments for serious diseases and conditions of therapeutic areas. The company was founded by Martin Shkreli in October 10, 2014 and is headquartered in New York, NY. | Pharmaceuticals: Major | Chief Executive Officer Comptroller/Controller/Auditor | |
First Contact Entertainment, Inc.
First Contact Entertainment, Inc. Packaged SoftwareTechnology Services First Contact Entertainment, Inc. operates as a virtual reality game company. It develops games for Vive, Oculus, Sony PSVR and Microsoft Mixed Reality platforms using Unreal Engine. The company was founded by Hess Barber and is headquartered in Santa Monica, CA. | Packaged Software | Founder | |
Gödel Systems, Inc.
Gödel Systems, Inc. Packaged SoftwareTechnology Services Gödel Systems, Inc. provides data, workflow and communications solutions. Its products include finance, law and science. The company was founded by Martin Shkrelli and is headquartered in New York, NY. | Packaged Software | Founder | |
Samsara Biocapital LLC
Samsara Biocapital LLC Investment ManagersFinance Samsara Biocapital LLC (Samsara Biocapital) is an independent venture capital firm founded in 2016 by Srinivas Akkaraju. The firm is headquartered in Palo Alto, California. | Investment Managers | Private Equity Investor | |
Neurogene, Inc.
Neurogene, Inc. BiotechnologyHealth Technology Neurogene, Inc. focuses on developing disease modifying therapeutics for severe neurologic diseases. Its pipeline includes multiple gene therapy products for ultra-rare diseases, as well as a novel technology that has the potential for use in monogenic autism spectrum disorders and indications not well suited for gene therapy. The company was founded by Rachel McMinn in January 2018 and is headquartered in New York, NY. | Biotechnology | Director/Board Member | |
KINNATE BIOPHARMA INC. | Pharmaceuticals: Major | Director/Board Member | |
Kalobios Pharmaceuticals, Inc. | Chairman Director/Board Member Director/Board Member | ||
JASPER THERAPEUTICS, INC. | Financial Conglomerates | Director of Finance/CFO Chief Executive Officer | |
PARDES BIOSCIENCES, INC. | Pharmaceuticals: Major | Director/Board Member |
Statistiques
Internationale
Etats-Unis | 43 |
Canada | 2 |
Suède | 2 |
Irlande | 2 |
Suisse | 2 |
Sectorielle
Health Technology | 22 |
Finance | 13 |
Consumer Services | 7 |
Technology Services | 5 |
Commercial Services | 3 |
Opérationnelle
Director/Board Member | 56 |
Independent Dir/Board Member | 24 |
Corporate Officer/Principal | 18 |
Chief Executive Officer | 18 |
Founder | 15 |
Relations les plus connectées
- Bourse
- Insiders
- Tony Chase
- Connexions Sociétés